CenExel

🏳️‍🌈 This Pride Month, we celebrate the diversity that strengthens our communities, workplaces, and research efforts.

At CenExel, we believe that advancing healthcare starts with inclusion. By fostering an environment where employees, study participants, and partners feel respected, valued, and represented, we help drive research that better reflects the communities we serve.

Together, we are committed to creating a culture of belonging while working to improve health outcomes for future generations.

Happy Pride Month! 💙

👋 Get to know the people driving research across the CenExel network.

Today we're highlighting Dr. Josh Rothstein, Principal Investigator at CenExel Atlanta. His diverse clinical background and commitment to advancing patient care help bring high-quality research opportunities to the communities we serve.

Myth vs. Reality: Clinical Trials Edition 🔍

There are a lot of misconceptions about clinical research. The reality? Clinical trials are more accessible than many people think.

✅ Studies may be available for both healthy volunteers and individuals with specific health conditions
✅ Health insurance is not required to participate
✅ Compensation opportunities may be available, depending on the study

By participating in clinical research, you can help advance medicine and contribute to future treatment options for patients worldwide.

Interested in learning more? Explore current study opportunities and see if you may qualify through the link in our bio.

🌍💙 Today is World Autism Awareness Day. 💙🌍

At CenExel, we are proud to support research that helps advance understanding and treatment options for individuals living with Autism Spectrum Disorder (ASD).

We are currently seeking adolescent volunteers to participate in an autism clinical trial. Clinical research plays an important role in expanding knowledge, improving care, and creating opportunities for future generations.

By participating in research, families can help contribute to scientific progress while supporting the development of potential new treatment options for ASD.

🔹 Adolescent volunteers needed
🔹 Autism Spectrum Disorder (ASD) clinical trial
🔹 Help advance research and understanding of autism

Learn more through the link in our bio!

New publication announcement 📣

CenExel is proud to support innovative research advancing potential new treatments for chronic neuropathic pain.

A Phase 1/2a trial evaluating KLS-2031, an investigational gene therapy for lumbosacral radiculopathy-induced neuropathic pain, has been published in PAIN Reports.

Congratulations to Dr. Todd Bertoch and the study team on this important publication and contribution to advancing gene therapy research!

Read more at the link in bio!

⭐️ Another reason we do what we do.

Huge shoutout to the incredible team at CenExel Decatur for creating such a welcoming and supportive experience for our participants. From first-time volunteers to returning patients, compassionate care leaves a lasting impact. 💙

Thank you to Nurses Delight, Victoria, Cheral, Maria, and Coordinator Justina for going above and beyond!

FDA momentum in psychedelic clinical research continues to grow, and CenExel is helping sponsors and CROs navigate the next generation of clinical development.

Our latest publication highlight showcases the specialized research capabilities, experienced investigators, and scalable patient access supporting psychedelic studies across the CenExel network.

🔗 Click the article link in bio to learn more!

May is Skin Cancer Awareness Month ☀️

Early detection can save lives. Knowing the ABCDEs of melanoma, Asymmetry, Border irregularity, Color variation, Diameter, and Evolving changes, can help you recognize when it’s time to speak with a healthcare professional.

At CenExel Clinical Research, we’re committed to advancing dermatology research and expanding access to innovative care through clinical trials that help shape the future of medicine.

Learn more about our clinical research studies and mission to improve patient outcomes at the link in bio!

Join CenExel at the 8th Annual Next Generation Ni****ne Delivery USA conference, taking place June 3 to 4 at the Hyatt Regency in Miami. As a leading CNS-focused CRO, CenExel is proud to join conversations driving innovation in to***co harm reduction, regulatory science, and next generation ni****ne delivery research!

Meet our team onsite:
• George Hardie, MSc MRSB MICR, Senior Director, To***co Harm Reduction
• Sara Castle, COO, CenExel Decatur
• Heather Beitz, MEd, CEO, CenExel Decatur
• Leslie Gibbs, CCRP, Director of Quality

We look forward to connecting with sponsors, industry leaders, and research partners advancing the future of smoke-free alternatives and clinical development.

****neDeliveryUSA ***coHarmReduction ****ne